爱多秀™(ETHOCEL™)药用级乙基纤维素聚合物
爱多秀™产品是获准用于全球制药行业的水不溶性乙基纤维素聚合物,常用于缓释固体剂型配方。
General Information
Tech Bulletin: ETHOCEL™ QbD Case Study
View and Download Send by EmailStudy on the influence of viscosity variation of ETHOCEL (ethylcellulose) on drug release from multiparticulate
dosage forms
Product Brochure
ETHOCEL™ Product Information Brochure
View and Download Send by EmailETHOCEL Product Information Brochure
Published Posters
AAPS 2008 - Investigation of Ethylcellulose in the Preparation of Theophylline ER Inert Matrix Tablets
View and Download Send by EmailInfluence of particle size and mol. wt.of ethylcellulose on drug release from inert matrices, with sparingly water soluble drug
AAPS 2012 - Stability of Ethylcellulose Barrier Membrane Coated Hydrochlorothiazide Matrices Comprising Starch 1500® or Lactose as Filler
View and Download Send by EmailStarch 1500 contributed to robustness of the barrier membrane coated matrix tablets.
AAPS 2014 - A QbD Investigation into the Effect of Ethylcellulose Viscosity Variation on the Drug Release of Metoprolol Tartrate Extended Release Multiparticulates
View and Download Send by EmailStudy showing that viscosity variation, within the manufacturer’s specifications for ETHOCEL Premium grades, has minimal impact on drug release for extended release multiparticulates.
AAPS 2015 - Feasibility of Taste-Masking a Highly Soluble Drug via Powder Layering with Fine Particle Ethylcellulose
View and Download Send by EmailAAPS 2015 Poster Reprint - Demonstrates the feasibility of ETHOCEL FP powder layering, onto drug loaded Suglets, as a highly efficient taste-masking technology.
AAPS 2017 - Stability Evaluation of Ethylcellulose Dry Powder Coated Metoprolol Tartrate Extended Release Multiparticulates
View and Download Send by EmailCRS 2008 - Influence of Solvent Type on ER Coating with Ethylcellulose Barrier Membranes
View and Download Send by EmailInfluence of solvent combinations on EC solution viscosity and drug release from coated beads
CRS 2008 - Investigation of Venlafaxine HCl Release from Extruded and Spheronized Beads Coated with Ethylcellulose using Organic or Aqueous Coating Systems
View and Download Send by EmailOrganic application of EC on venlafaxine HCl extruded and
spheronized beads resulted in a consistent drug release
CRS 2009 - Influence of Coating System Type on Acetaminophen Release from Ethylcellulose Barrier Membrane Coated Multiparticulates
View and Download Send by EmailADS adapted from 2009 CRS poster,The Influence of Coating System Type on Acetaminophen Release from Ethylcellulose Barrier Membrane Coated Multiparticulates
CRS 2009 - Influence of Molecular Weight on Drug Release from Ethylcellulose Barrier Membrane Multiparticulates
View and Download Send by EmailDrug release is retarded with increasing molecular weight (viscosity) of EC
CRS 2010 - Influence of Pore-Former on Drug Release from Ethylcellulose Coated Multiparticulates
View and Download Send by EmailMultiparticulate beads coated with ethylcellulose from an organic solution
CRS 2011 - Influence of Dissolution Media pH on Drug Release from Ethylcellulose Coated Multiparticulates
View and Download Send by EmailComparative evaluation in gastric and intestinal pH media for ionic or non-ionic drugs
CRS 2011 - Influence of Drug Solubility on Release from Ethylcellulose Barrier Membrane Coated Multiparticulates
View and Download Send by EmailSolvent coateding lead to slower drug release than when coated with aqueous dispersion and drug release rate increased with addition of hypromellose as a pore-former
CRS 2014 - Investigation of the Effect of Ethylcellulose Viscosity Variation Using QbD Samples on Drug Release from Extended Release Multiparticulates
View and Download Send by EmailEffect of viscosity variation for ETHOCEL™ QbD samples (Std. 10, 20 and 100 Premium grades) coated onto drug layered multiparticlates.
主要的药物应用:
- 多微粒缓释包衣
- 活性成分的微囊
- 药物的苦味遮盖剂
- 惰性骨架系统中的缓释粘合剂
- 溶剂和挤压制粒
爱多秀™乙基纤维素为制药应用提供了灵活的配方:
- 不同的分子量范围,可以组成中等粘度的混合物
- 具有超细粉末(FP)规格,可用于惰性缓释骨架系统,并且可通过增大表面积而改善亲脂性
- 与水溶性辅料(例如美多秀™优质纤维素醚类)配合使用时,能调节释放性能
制药行业已经广泛应用爱多秀™达50年以上。本品具有优异的安全记录,得到了全球制药行业的认可,并且符合《美国食用化学品集》的要求,在欧洲和美国还被许可用作食品添加剂。
爱多秀™/美多秀™/ETHOCEL™ / METHOCEL™ IFF公司注册商标。 © 2021 IFF.版权所有
Platform Solutions
Colorcon can help to reduce your project time by providing the right solution through excipient selection and process guidance.
Productivity
Lower total cost and reduce time to market
Dissolution Design
Life cycle management through modified delivery profiles and product line extensions
Patient Adherence
Reduce medication errors and improve patient adherence
Stability
Stable and consistent product performance
Product Authentication
Track and trace